Pharmacobiochemistry of arylalkyltriazenes and their application in cancer chemotherapy.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001711:Biotransformation; D002273:Carcinogens; D003606:Dacarbazine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009153:Mutagens; D009369:Neoplasms / Q000188:drug therapy*; D013329:Structure-Activity Relationship; D014226:Triazenes / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity
D000970:Antineoplastic Agents; D002273:Carcinogens; D009153:Mutagens; D014226:Triazenes; D003606:Dacarbazine